Cargando…

Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls

BACKGROUND: Cardiac Rubidium‐82 ((82)Rb) positron emission tomography/computed tomography (PET/CT) provides a measure of the myocardial blood flow and the myocardial flow reserve, which reflects the function of both large epicardial arteries and the myocardial microcirculation. Knowledge on changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Ida K. B., Hasbak, Philip, von Scholten, Bernt J., Laursen, Jens C., Zobel, Emilie H., Jorge Diaz, Lars, Holmvang, Lene, Ripa, Rasmus S., Rossing, Peter, Kjaer, Andreas, Hansen, Tine W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research: Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248340/ https://www.ncbi.nlm.nih.gov/pubmed/33434331 http://dx.doi.org/10.1111/dme.14517

Ejemplares similares

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls
por: Laursen, Jens Christian, et al.
Publicado: (2021)

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes
por: Zobel, Emilie H., et al.
Publicado: (2020)

Myocardial flow reserve assessed by cardiac (82)Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetes
por: Zobel, Emilie H, et al.
Publicado: (2019)

Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
por: Zobel, Emilie H., et al.
Publicado: (2021)

Effect of Liraglutide on Vascular Inflammation Evaluated by [(64)Cu]DOTATATE
por: Zobel, Emilie H., et al.
Publicado: (2021)

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [(64)Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jensen, Jacob K., et al.
Publicado: (2021)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Effect of Liraglutide on Arterial Inflammation Assessed as [(18)F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Ripa, Rasmus S., et al.
Publicado: (2021)

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R(+) T cells
por: von Scholten, Bernt Johan, et al.
Publicado: (2016)

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials
por: Zobel, Emilie H., et al.
Publicado: (2021)

Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography
por: Lassen, Martin Lyngby, et al.
Publicado: (2023)

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
por: Wretlind, Asger, et al.
Publicado: (2022)

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment
por: Zobel, Emilie H., et al.
Publicado: (2019)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023)

Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
por: Arita, Ryoichi, et al.
Publicado: (2009)

Sex Differences in Coronary Microvascular Function in Individuals With Type 2 Diabetes
por: Haas, Andrea V., et al.
Publicado: (2019)

Editorial: Advanced Cardiovascular Imaging in Diabetes
por: Schick, Fritz, et al.
Publicado: (2022)

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes
por: Hur, Junguk, et al.
Publicado: (2015)

Persons with type 1 diabetes have low blood oxygen levels in the supine and standing body positions
por: Laursen, Jens Christian, et al.
Publicado: (2021)

Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
por: Garg, Rajesh, et al.
Publicado: (2015)

Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway
por: Huang, Chao, et al.
Publicado: (2018)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
por: Li Calzi, Sergio, et al.
Publicado: (2008)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Myocardial perfusion recovery induced by an α-calcitonin gene-related peptide analogue
por: Bentsen, Simon, et al.
Publicado: (2021)

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
por: Ghotbi, Adam Ali, et al.
Publicado: (2017)

Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G
por: Knudsen, Andreas, et al.
Publicado: (2018)

Subacute cardiac rubidium-82 positron emission tomography ((82)Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMI
por: Ghotbi, Adam Ali, et al.
Publicado: (2016)

Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients
por: Mogensen, Ulrik Madvig, et al.
Publicado: (2012)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Targeted Inhibition of Calpain Reduces Myocardial Hypertrophy and Fibrosis in Mouse Models of Type 1 Diabetes
por: Li, Ying, et al.
Publicado: (2011)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Comparison of the Peripheral Reactive Hyperemia Index with Myocardial Perfusion Reserve by (82)Rb PET/CT in HIV-Infected Patients
por: Ørbæk, Mathilde, et al.
Publicado: (2017)

Deficiency of Rac1 Blocks NADPH Oxidase Activation, Inhibits Endoplasmic Reticulum Stress, and Reduces Myocardial Remodeling in a Mouse Model of Type 1 Diabetes
por: Li, Jianmin, et al.
Publicado: (2010)

Diminished Alveolar Microvascular Reserves in Type 2 Diabetes Reflect Systemic Microangiopathy
por: Chance, William W., et al.
Publicado: (2008)

Diabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice
por: Parathath, Saj, et al.
Publicado: (2011)

Visual impairment and mortality in patients with type 2 diabetes
por: Siersma, Volkert, et al.
Publicado: (2019)

Rubidium-82 PET imaging is feasible in a rat myocardial infarction model
por: Ghotbi, Adam Ali, et al.
Publicado: (2017)

GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop
por: Giacco, Ferdinando, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4kmk6ae8r2nf35bi4i0olc9cs6